Bixia Liu

2.5k total citations · 1 hit paper
36 papers, 1.3k citations indexed

About

Bixia Liu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bixia Liu has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Immunology. Recurrent topics in Bixia Liu's work include RNA modifications and cancer (9 papers), Cancer-related gene regulation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Bixia Liu is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related gene regulation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Bixia Liu collaborates with scholars based in China, Hong Kong and United States. Bixia Liu's co-authors include Li Zhu, Jieer Ying, Haijun Zhong, Qi Xu, Cong Luo, Xi‐jian Dai, Honghan Gong, Haiqing Zhang, Weidong Ji and Xiaoling Ying and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Advanced Science.

In The Last Decade

Bixia Liu

36 papers receiving 1.3k citations

Hit Papers

Hepatogastroenterology 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bixia Liu China 16 391 329 307 246 230 36 1.3k
Daisuke Mori Japan 19 300 0.8× 268 0.8× 257 0.8× 208 0.8× 75 0.3× 64 1.2k
Jing Yuan China 26 614 1.6× 244 0.7× 212 0.7× 74 0.3× 62 0.3× 67 2.1k
Lei Qin China 22 663 1.7× 173 0.5× 120 0.4× 305 1.2× 37 0.2× 96 1.5k
Cheng‐Ming Hsu Taiwan 22 456 1.2× 272 0.8× 229 0.7× 332 1.3× 45 0.2× 107 1.7k
Qiang Ding China 21 482 1.2× 347 1.1× 179 0.6× 324 1.3× 34 0.1× 75 1.3k
Xiaofeng Wu China 24 899 2.3× 456 1.4× 202 0.7× 231 0.9× 43 0.2× 105 2.0k
Tomasz Kręcicki Poland 18 313 0.8× 194 0.6× 177 0.6× 201 0.8× 114 0.5× 94 1.1k
Jiani Wu China 18 534 1.4× 334 1.0× 151 0.5× 483 2.0× 42 0.2× 80 1.6k
Ruihua Ma China 18 732 1.9× 165 0.5× 96 0.3× 107 0.4× 29 0.1× 32 1.3k

Countries citing papers authored by Bixia Liu

Since Specialization
Citations

This map shows the geographic impact of Bixia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bixia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bixia Liu more than expected).

Fields of papers citing papers by Bixia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bixia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bixia Liu. The network helps show where Bixia Liu may publish in the future.

Co-authorship network of co-authors of Bixia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Bixia Liu. A scholar is included among the top collaborators of Bixia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bixia Liu. Bixia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yanxia, Lihong Wei, Bixia Liu, et al.. (2024). Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer. Drug Resistance Updates. 76. 101117–101117. 4 indexed citations
2.
Luo, Baohong, Yu Sun, Yuting Luo, et al.. (2024). Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma. Clinical and Translational Medicine. 14(1). e1553–e1553. 4 indexed citations
3.
Li, Xin, Bixia Liu, Yan Zheng, et al.. (2024). Potent human antibodies against SpA5 identified by high-throughput single-cell sequencing of phase I clinical volunteers’ B cells. iScience. 28(1). 111627–111627. 1 indexed citations
4.
Shu, Man, Leilei Huang, Shuhua Li, et al.. (2024). Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma. Cancer Letters. 593. 216835–216835. 1 indexed citations
5.
Liu, Bixia, Yang Xie, Jiayu Zhang, et al.. (2024). SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway. International Immunopharmacology. 131. 111759–111759. 17 indexed citations
6.
Peng, Hao, et al.. (2024). Stimuli-responsive chitosan based nanoparticles in cancer therapy and diagnosis: A review. International Journal of Biological Macromolecules. 283(Pt 3). 137709–137709. 6 indexed citations
7.
Liu, Bixia, Yifan Lv, Yapeng Huang, et al.. (2024). m6A modification mediates SLC3A2/SLC7A5 translation in 3-methylcholanthrene-induced uroepithelial transformation. Cell Biology and Toxicology. 40(1). 5–5. 3 indexed citations
8.
Liu, Bixia, Yuting Luo, Yanxia Wang, et al.. (2023). New insights into the correlations between circulating tumor cells and target organ metastasis. Signal Transduction and Targeted Therapy. 8(1). 465–465. 72 indexed citations
9.
Hu, Chenxi, Jie Ning, Xiaoling Ying, et al.. (2023). N6-methyladenosine mediates Nrf2 protein expression involved in PM2.5-induced pulmonary fibrosis. Ecotoxicology and Environmental Safety. 254. 114755–114755. 24 indexed citations
10.
Ying, Xiaoling, Yapeng Huang, Bixia Liu, et al.. (2023). Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx–m6A editor inhibits bladder cancer development. Journal of Advanced Research. 56. 57–68. 14 indexed citations
11.
Liu, Bixia, et al.. (2022). Risk of inflammatory bowel disease appears to vary across different frequency, amount, and subtype of alcoholic beverages. Frontiers in Nutrition. 9. 918754–918754. 10 indexed citations
12.
Ying, Xiaoling, Bixia Liu, Yapeng Huang, et al.. (2021). METTL1‐m7G‐EGFR/EFEMP1 axis promotes the bladder cancer development. SHILAP Revista de lepidopterología. 11(12). e675–e675. 137 indexed citations
13.
Liu, Bixia, Chao‐Tao Tang, Xi‐jian Dai, et al.. (2021). Prognostic Value of S100P Expression in Patients With Digestive System Cancers: A Meta-Analysis. Frontiers in Oncology. 11. 593728–593728. 7 indexed citations
14.
Dai, Xi‐jian, Bixia Liu, Sizhi Ai, et al.. (2019). Altered inter-hemispheric communication of default-mode and visual networks underlie etiology of primary insomnia. Brain Imaging and Behavior. 14(5). 1430–1444. 32 indexed citations
15.
Dai, Xi‐jian, Jian Jiang, Zhiqiang Zhang, et al.. (2018). Plasticity and Susceptibility of Brain Morphometry Alterations to Insufficient Sleep. Frontiers in Psychiatry. 9. 266–266. 53 indexed citations
16.
Liu, Xuming, et al.. (2018). Altered connection properties of important network hubs may be neural risk factors for individuals with primary insomnia. Scientific Reports. 8(1). 5891–5891. 39 indexed citations
17.
Ying, Jieer, et al.. (2015). The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis. OncoTargets and Therapy. 8. 2427–2427. 47 indexed citations
18.
Zhu, Li, Bixia Liu, Luying Liu, et al.. (2014). High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab. Journal of Cancer Research and Therapeutics. 10(8). 246–246. 16 indexed citations
19.
Dai, Xi‐jian, Bixia Liu, Heng Liu, et al.. (2014). Cerebellar cryptococcosis characterized by a space-occupying lesion in an immunocompetent non-HIV patient. Neuropsychiatric Disease and Treatment. 11. 21–21. 8 indexed citations
20.
Dai, Xi‐jian, Honghan Gong, Yì Wáng, et al.. (2012). Gender differences in brain regional homogeneity of healthy subjects after normal sleep and after sleep deprivation: A resting-state fMRI study. Sleep Medicine. 13(6). 720–727. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026